• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆蛋白质组学分析揭示了颅内动脉瘤形成和破裂的潜在生物标志物。

Plasma proteomics analysis reveals potential biomarkers for intracranial aneurysm formation and rupture.

机构信息

Institute of Neurology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China.

Institute of Neurology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China.

出版信息

J Proteomics. 2024 Jul 15;303:105216. doi: 10.1016/j.jprot.2024.105216. Epub 2024 Jun 5.

DOI:10.1016/j.jprot.2024.105216
PMID:38849112
Abstract

The aim of this study was to investigate the plasma proteome in individuals with intracranial aneurysms (IAs) and identify biomarkers associated with the formation and rupture of IAs. Proteomic profiles (N = 1069 proteins) were assayed in plasma (N = 120) collected from patients with ruptured and unruptured intracranial aneurysms (RIA and UIA), traumatic subarachnoid hemorrhage (tSAH), and healthy controls (HC) using tandem mass tag (TMT) labeling quantitative proteomics analysis. Gene ontology (GO) and pathway analysis revealed that these relevant proteins were involved in immune response and extracellular matrix organization pathways. Seven candidate biomarkers were verified by ELISA in a completely separate cohort for validation (N = 90). Among them, FN1, PON1, and SERPINA1 can be utilized as diagnosis biomarkers of IA, with a combined area under the ROC curve of 0.891. The sensitivity was 93.33%, specificity was 75.86%, and accuracy was 87.64%. PFN1, ApoA-1, and SERPINA1 can serve as independent risk factors for predicting aneurysm rupture. The combined prediction of aneurysm rupture yielded an area under the ROC curve of 0.954 with a sensitivity of 96.15%, specificity of 81.48%, and accuracy of 88.68%. This prediction model was more effective than PHASES score. In conclusion, high-throughput proteomics analysis with population validation was performed to assess blood-based protein expression characteristics. This revealed the potential mechanism of IA formation and rupture, facilitating the discovery of biomarkers. SIGNIFICANCE: Although the annual rupture rate of small unruptured aneurysms is believed to be minimal, studies have indicated that ruptured aneurysms typically have an average size of 6.28 mm, with 71.8% of them being <7 mm in diameter. Hence, evaluating the possibility of rupture in UIA and making a choice between aggressive treatment and conservative observation emerges as a significant challenge in the management of UIA. No biomarker or scoring system has been able to satisfactorily address this issue to date. It would be significant to develop biomarkers that could be used for early diagnosis of IA as well as for prediction of IA rupture. After TMT proteomics analysis and ELISA validation in independent populations, we found that FN1, PON1, and SERPINA1 can be utilized as diagnostic biomarkers for IA, and PFN1, ApoA-1, and SERPINA1 can serve as independent risk factors for predicting aneurysm rupture. Especially, when combined with ApoA-1, SERPINA1, and PFN1 for predicting IA rupture, the area under the curve (AUC) was 0.954 with a sensitivity of 96.15%, specificity of 81.48%, and accuracy of 88.68%. This prediction model was more effective than PHASES score.

摘要

本研究旨在探讨颅内动脉瘤(IA)患者的血浆蛋白质组学,并鉴定与 IA 形成和破裂相关的生物标志物。使用串联质量标签(TMT)标记定量蛋白质组学分析,对收集自破裂颅内动脉瘤(RIA)和未破裂颅内动脉瘤(UIA)、创伤性蛛网膜下腔出血(tSAH)和健康对照(HC)患者的血浆(N=120)中的蛋白质组学图谱(N=1069 种蛋白质)进行检测。基因本体(GO)和途径分析表明,这些相关蛋白参与免疫反应和细胞外基质组织途径。在一个完全独立的队列中,通过 ELISA 验证了 7 个候选生物标志物进行验证(N=90)。其中,FN1、PON1 和 SERPINA1 可用作 IA 的诊断生物标志物,ROC 曲线下面积为 0.891。灵敏度为 93.33%,特异性为 75.86%,准确性为 87.64%。PFN1、ApoA-1 和 SERPINA1 可作为预测动脉瘤破裂的独立危险因素。对动脉瘤破裂的联合预测得出 ROC 曲线下面积为 0.954,灵敏度为 96.15%,特异性为 81.48%,准确性为 88.68%。该预测模型比 PHASES 评分更有效。总之,进行了高通量蛋白质组学分析和人群验证,以评估基于血液的蛋白质表达特征。这揭示了 IA 形成和破裂的潜在机制,有助于发现生物标志物。意义:尽管人们认为小未破裂动脉瘤的年破裂率很小,但研究表明,破裂的动脉瘤通常平均直径为 6.28mm,其中 71.8%的直径<7mm。因此,评估 UIA 的破裂可能性并在积极治疗和保守观察之间做出选择,是 UIA 管理中的一个重大挑战。到目前为止,还没有一种生物标志物或评分系统能够令人满意地解决这个问题。开发能够用于 IA 的早期诊断以及预测 IA 破裂的生物标志物将具有重要意义。在独立人群中进行 TMT 蛋白质组学分析和 ELISA 验证后,我们发现 FN1、PON1 和 SERPINA1 可用作 IA 的诊断生物标志物,PFN1、ApoA-1 和 SERPINA1 可用作预测动脉瘤破裂的独立危险因素。特别是,当用于预测 IA 破裂时,结合 ApoA-1、SERPINA1 和 PFN1 的曲线下面积(AUC)为 0.954,灵敏度为 96.15%,特异性为 81.48%,准确性为 88.68%。该预测模型比 PHASES 评分更有效。

相似文献

1
Plasma proteomics analysis reveals potential biomarkers for intracranial aneurysm formation and rupture.血浆蛋白质组学分析揭示了颅内动脉瘤形成和破裂的潜在生物标志物。
J Proteomics. 2024 Jul 15;303:105216. doi: 10.1016/j.jprot.2024.105216. Epub 2024 Jun 5.
2
Glypican-1 may be a plasma biomarker for predicting the rupture of small intracranial aneurysms.Glypican-1 可能是一种预测颅内小动脉瘤破裂的血浆生物标志物。
J Proteomics. 2024 Feb 20;293:105060. doi: 10.1016/j.jprot.2023.105060. Epub 2023 Dec 26.
3
Identification of the soluble form of tyrosine kinase receptor Axl as a potential biomarker for intracranial aneurysm rupture.鉴定酪氨酸激酶受体Axl的可溶性形式作为颅内动脉瘤破裂的潜在生物标志物。
BMC Neurol. 2015 Mar 5;15:23. doi: 10.1186/s12883-015-0282-8.
4
Biomarkers from circulating neutrophil transcriptomes have potential to detect unruptured intracranial aneurysms.循环中性粒细胞转录组的生物标志物具有检测未破裂颅内动脉瘤的潜力。
J Transl Med. 2018 Dec 28;16(1):373. doi: 10.1186/s12967-018-1749-3.
5
Intracranial Aneurysm Biomarker Candidates Identified by a Proteome-Wide Study.通过全蛋白质组研究确定的颅内动脉瘤生物标志物候选物
OMICS. 2020 Aug;24(8):483-492. doi: 10.1089/omi.2020.0057. Epub 2020 Jun 11.
6
Quantitative proteomics analysis of differentially expressed proteins in ruptured and unruptured cerebral aneurysms by iTRAQ.iTRAQ 技术分析破裂与未破裂脑动脉瘤差异表达蛋白的定量蛋白质组学研究
J Proteomics. 2018 Jun 30;182:45-52. doi: 10.1016/j.jprot.2018.05.001. Epub 2018 May 3.
7
Comparison of Rupture Risk of Intracranial Aneurysms Between Familial and Sporadic Patients.颅内动脉瘤患者中家族性与散发性动脉瘤破裂风险的比较。
Stroke. 2019 Jun;50(6):1380-1383. doi: 10.1161/STROKEAHA.118.023783. Epub 2019 Apr 23.
8
Size ratio correlates with intracranial aneurysm rupture status: a prospective study.瘤体大小比值与颅内动脉瘤破裂状态相关:一项前瞻性研究。
Stroke. 2010 May;41(5):916-20. doi: 10.1161/STROKEAHA.109.574244. Epub 2010 Apr 8.
9
Comprehensive mass spectrometry for development of proteomic biomarkers of intracranial aneurysms.综合质谱法用于颅内动脉瘤蛋白质组生物标志物的开发。
Talanta. 2022 Apr 1;240:123159. doi: 10.1016/j.talanta.2021.123159. Epub 2021 Dec 20.
10
Evaluation of PHASES Score for Predicting Rupture of Intracranial Aneurysms: Significance of Aneurysm Size.评估 PHASES 评分对颅内动脉瘤破裂的预测价值:瘤体大小的意义。
World Neurosurg. 2024 Apr;184:e178-e184. doi: 10.1016/j.wneu.2024.01.077. Epub 2024 Jan 20.